Subscribe to Newsletter

Content by Stephanie Vine:

Business & Regulation Standards & Regulation

Making European Regulations Work

| Stephanie Vine

Pathways designed to bring medicines to market faster in Europe are not delivering the goods

Business & Regulation

Endolysins Vs MRSA

| Stephanie Vine

What is an endolysin? We spoke with Bjorn Herpers from the Regional Public Health Laboratory Kennemerland, Haarlem, in the Netherlands to find out.

Discovery & Development Drug Delivery

Dosing to Circadian Rhythm

| Stephanie Vine

Could medicines be made more effective with better timing?

Business & Regulation Standards & Regulation

Regulators Target Ebola

| Stephanie Vine

Will FDA fast review and voucher incentives make a difference?

Business & Regulation Business Practice

Care to ‘Patent Dance’?

| Stephanie Vine

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

Business & Regulation Drug Discovery

Battle of the Superbugs

| Stephanie Vine

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

Business & Regulation Business Practice

Access All Areas

| Stephanie Vine

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

Manufacture Small Molecules

The Final Frontier?

| Stephanie Vine

The Galactic Grant Competition encourages companies to use the International Space Station for pharmaceutical R&D

Business & Regulation Business Practice

Liking Social Pharma

| Stephanie Vine, Charlotte Barker

Patients and physicians are tweeting, snapchatting, pinning and posting about healthcare, – some are making the leap into the digital world.

Manufacture Small Molecules

Antibiotic Apocalypse: Part II

| Stephanie Vine

The rise of drug resistance has left us facing a future with few effective antibiotics. Do the next-generation antibiotics in the pipeline offer hope?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register